trying to make a deal for Methano  . 
"Oracle Energy Corp. has entered into negotiations with Methanogenesis Corp. (Methano) to acquire Methano. The Company is also contemplating a concurrent move to the Canadian Securities Exchange ("CSE").

Oracle proposes to acquire Methano by way of a share exchange (the "Share Exchange"), and the Company will be providing further details if, as and when discussions are formalized in an agreement (the "Proposed Agreement") to complete the proposed acquisition of Methano (the "Transaction").

About Methanogenesis Corporation

Methano is a Canadian corporation organized to combine microbiological approaches with genetics and metabolic engineering to produce genetically modified microbes "GMOs" for the efficient and cost-effective conversion of methane CH4 to methanol CH3OH.

Oracle Financing

The Transaction will be subject to the completion of a non-brokered private placement financing by Oracle of up to $1,000,000 (the "Financing") which, when added to Methano's post-closing working capital, will provide sufficient capital to satisfy working capital and financial resources in order for the Company to carry out its financial plan for a minimum of six months post-closing of the Transaction.

Subsequent News Release

Oracle will disseminate a subsequent news release if the Proposed Agreement is entered into. The subsequent news release will address various outstanding issues including biographies on the management of Methano and on any new directors of the Company; the details of a research agreement between Methano and a university; and the details of the proposed financing to be completed in conjunction with the closing of the Transaction.

Regulatory Matters

Assuming that the Proposed Agreement is consummated it is anticipated that the Transaction will form the basis of a qualification for listing under the policies of the CSE.

There is no assurance that the Transaction or the Financing will be completed. All sales, exchanges, and issuances of any units, shares, warrants, and securities in connection to the Financing and the Transaction will be subject to regulatory approval including, but not limited to, the approval of the CSE"